Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Myoclonic epilepsy of Lafora 1"
Page 1
The impact of COVID-19 lockdown on child and adolescent mental health: systematic review.
Eur Child Adolesc Psychiatry. 2023 Jul;32(7):1151-1177. doi: 10.1007/s00787-021-01856-w. Epub 2021 Aug 18.
Eur Child Adolesc Psychiatry. 2023.
PMID: 34406494
Free PMC article.
Review.
Anxiety symptoms and depression symptoms were common in the included studies and ranged 1.8-49.5% and 2.2-63.8%, respectively. Irritability (range = 16.7-73.2%) and anger (range = 30.0-51.3%), were also frequently reported by children and adolescents. ...
Anxiety symptoms and depression symptoms were common in the included studies and ranged 1.8-49.5% and 2.2-63.8%, respectively. Irrita …
Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data.
Pondrelli F, Minardi R, Muccioli L, Zenesini C, Vignatelli L, Licchetta L, Mostacci B, Tinuper P, Vander Kooi CW, Gentry MS, Bisulli F.
Pondrelli F, et al.
Orphanet J Rare Dis. 2023 Sep 2;18(1):263. doi: 10.1186/s13023-023-02880-6.
Orphanet J Rare Dis. 2023.
PMID: 37658439
Free PMC article.
BACKGROUND: Lafora disease (LD) is a fatal form of progressive myoclonic epilepsy caused by biallelic pathogenic variants in EPM2A or NHLRC1. ...METHODS: We collected all reported cases with genetically-confirmed LD containing data on disease hi …
BACKGROUND: Lafora disease (LD) is a fatal form of progressive myoclonic epilepsy caused by biallelic pathogenic …
Item in Clipboard
Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis.
Pondrelli F, Muccioli L, Licchetta L, Mostacci B, Zenesini C, Tinuper P, Vignatelli L, Bisulli F.
Pondrelli F, et al.
Orphanet J Rare Dis. 2021 Aug 16;16(1):362. doi: 10.1186/s13023-021-01989-w.
Orphanet J Rare Dis. 2021.
PMID: 34399803
Free PMC article.
BACKGROUND: Lafora disease (LD) is a rare fatal autosomal recessive form of progressive myoclonus epilepsy. ...RESULTS: Seventy-three papers describing 298 genetically confirmed LD cases were selected. Mean age at disease onset was 13.4 years (SD 3.7), …
BACKGROUND: Lafora disease (LD) is a rare fatal autosomal recessive form of progressive myoclonus epilepsy. ...RESULTS: …
Item in Clipboard
FDG-PET assessment and metabolic patterns in Lafora disease.
Muccioli L, Farolfi A, Pondrelli F, d'Orsi G, Michelucci R, Freri E, Canafoglia L, Licchetta L, Toni F, Bonfiglioli R, Civollani S, Pettinato C, Maietti E, Marotta G, Fanti S, Tinuper P, Bisulli F.
Muccioli L, et al.
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1576-1584. doi: 10.1007/s00259-019-04647-3. Epub 2019 Dec 19.
Eur J Nucl Med Mol Imaging. 2020.
PMID: 31858178
PURPOSE: To describe cerebral glucose metabolism pattern as assessed by (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) in Lafora disease (LD), a rare, lethal form of progressive myoclonus epilepsy caused by biallelic mutations in EPM2A or NHL …
PURPOSE: To describe cerebral glucose metabolism pattern as assessed by (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) in …
Item in Clipboard
Cite
Cite